Zeytun, E. Et Al. 2021. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.21, no.9 , 1099-1109.

Zeytun, E., ALTINTOP, M. D., SEVER, B., ÖZDEMİR, A., Ellakwa, D. E., Ocak, Z., ... Ciftci, H. I.(2021). A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.21, no.9, 1099-1109.

Zeytun, Ebru Et Al. "A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors," ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.21, no.9, 1099-1109, 2021

Zeytun, Ebru Et Al. "A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors." ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.21, no.9, pp.1099-1109, 2021

Zeytun, E. Et Al. (2021) . "A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors." ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.21, no.9, pp.1099-1109.

@article{article, author={Ebru Zeytun Et Al. }, title={A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors}, journal={ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY}, year=2021, pages={1099-1109} }